Is this the new Ozempic? The doctor who believes that peptides therapy could be the key to a longer life - The molecules ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

None had been diagnosed with Alzheimer disease and related dementias at the start of the study. The researchers discovered that people who took GLP-1 receptor agonists (like Ozempic) or a type of ...

New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce the risk of Alzheimer's disease and dementia.

Research has found that weight-loss drugs such as Ozempic may help curb addictive behaviours, such as alcohol addiction. One ...

A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two common anti-diabetes ...

Alzheimer's is the most common form of dementia ... which is the active ingredient in Ozempic and Wegovy. Ozempic is not marketed as a weight loss drug and is prescribed to those with type ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

The state’s largest commercial health insurer will stop covering a popular class of prescription drugs for weight loss, ...